AR020022A1 - COMPOSICIONES DE ANTíGENOS DE ERYSILOPELOTHRIX RHUSIOPATHIAE, SU USO EN LA PREPARACIoN DE MEDICAMENTOS Y COMPOSICIONES DE VACUNAS. - Google Patents

COMPOSICIONES DE ANTíGENOS DE ERYSILOPELOTHRIX RHUSIOPATHIAE, SU USO EN LA PREPARACIoN DE MEDICAMENTOS Y COMPOSICIONES DE VACUNAS.

Info

Publication number
AR020022A1
AR020022A1 ARP990106727A ARP990106727A AR020022A1 AR 020022 A1 AR020022 A1 AR 020022A1 AR P990106727 A ARP990106727 A AR P990106727A AR P990106727 A ARP990106727 A AR P990106727A AR 020022 A1 AR020022 A1 AR 020022A1
Authority
AR
Argentina
Prior art keywords
compositions
antigens
rhusiopathiae
erysilopelothrix
vaccines
Prior art date
Application number
ARP990106727A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR020022A1 publication Critical patent/AR020022A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Composiciones estabilizadas de antígenos de Erysipelothrix rhusiopathiae y a formulaciones de vacunas que contienen dichas composiciones de antígenos. Losantígenos del invento son eficaces para proporcionar una proteccion a largo plazo contra erisipela en animales.
ARP990106727A 1999-01-29 1999-12-23 COMPOSICIONES DE ANTíGENOS DE ERYSILOPELOTHRIX RHUSIOPATHIAE, SU USO EN LA PREPARACIoN DE MEDICAMENTOS Y COMPOSICIONES DE VACUNAS. AR020022A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11770499P 1999-01-29 1999-01-29

Publications (1)

Publication Number Publication Date
AR020022A1 true AR020022A1 (es) 2002-03-27

Family

ID=22374369

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990106727A AR020022A1 (es) 1999-01-29 1999-12-23 COMPOSICIONES DE ANTíGENOS DE ERYSILOPELOTHRIX RHUSIOPATHIAE, SU USO EN LA PREPARACIoN DE MEDICAMENTOS Y COMPOSICIONES DE VACUNAS.

Country Status (17)

Country Link
EP (1) EP1027895B1 (es)
JP (3) JP3535436B2 (es)
CN (1) CN1210062C (es)
AR (1) AR020022A1 (es)
AT (1) ATE386540T1 (es)
AU (1) AU776847B2 (es)
BR (1) BR9905853B1 (es)
CA (1) CA2290078C (es)
CY (1) CY1107910T1 (es)
DE (1) DE69938168T2 (es)
DK (1) DK1027895T3 (es)
ES (1) ES2301230T3 (es)
HK (1) HK1029062A1 (es)
NZ (1) NZ501128A (es)
PT (1) PT1027895E (es)
TW (1) TW546146B (es)
ZA (1) ZA997138B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637047B2 (en) * 2003-10-30 2014-01-28 Boehringer Ingelheim Vetmedica, Inc. Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
CN107496913A (zh) * 2017-09-15 2017-12-22 天津瑞普生物技术股份有限公司 猪丹毒、猪细小病毒、猪流感病毒三联灭活疫苗制备方法
CN107648599A (zh) * 2017-09-18 2018-02-02 天津瑞普生物技术股份有限公司 一种猪丹毒、猪细小病毒二联灭活疫苗的制备方法
CN110812473A (zh) * 2019-12-10 2020-02-21 广东君睿生物技术研究有限公司 一种副猪嗜血杆菌病、猪链球菌病和猪多杀性巴氏杆菌病三联灭活疫苗及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294071A3 (en) * 1987-06-03 1990-08-01 Merck & Co. Inc. Hepatitis b vaccines made with pre-formed aluminum hydroxide gels, and processes thereof
US5695769A (en) * 1990-06-13 1997-12-09 Pfizer Inc. Pasteurella multocida toxoid vaccines
ES2194841T3 (es) * 1991-11-15 2003-12-01 Pfizer Procedimiento de produccion de vacunas bacterianas gram negativas.
US5690942A (en) * 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
JP3072345B1 (ja) * 1999-03-31 2000-07-31 農林水産省家畜衛生試験場長 豚丹毒菌の組換えサブユニットワクチン

Also Published As

Publication number Publication date
BR9905853A (pt) 2000-11-14
ATE386540T1 (de) 2008-03-15
CA2290078A1 (en) 2000-07-29
CY1107910T1 (el) 2013-09-04
DE69938168D1 (de) 2008-04-03
JP2000219637A (ja) 2000-08-08
JP4714167B2 (ja) 2011-06-29
JP2003160507A (ja) 2003-06-03
AU776847B2 (en) 2004-09-23
ES2301230T3 (es) 2008-06-16
BR9905853B1 (pt) 2011-11-01
AU5944599A (en) 2000-08-03
PT1027895E (pt) 2008-03-18
ZA997138B (en) 2001-05-16
TW546146B (en) 2003-08-11
JP3535436B2 (ja) 2004-06-07
NZ501128A (en) 2001-12-21
JP2007119499A (ja) 2007-05-17
DK1027895T3 (da) 2008-06-09
DE69938168T2 (de) 2009-02-26
CN1262129A (zh) 2000-08-09
EP1027895A2 (en) 2000-08-16
EP1027895A3 (en) 2001-07-18
CN1210062C (zh) 2005-07-13
EP1027895B1 (en) 2008-02-20
CA2290078C (en) 2013-01-22
HK1029062A1 (en) 2001-03-23

Similar Documents

Publication Publication Date Title
ES2140076T3 (es) Vacunas que contienen una saponina y un esterol.
AR044985A1 (es) Metodo y parche de inmunizacion por disposicion de microproyeccion
DE60012042D1 (de) Entepneumovirus und entsprechendes impfstoff
NO20023829L (no) Proteosom influensavaksine
NO20015073L (no) Vaksiner
ES2585810T3 (es) Uso de un virus de la gripe y un adyuvante de emulsión de aceite en agua para inducir respuesta de células T CD4 y/o una respuesta de células B de memoria mejorada
UY26555A1 (es) Composición farmacéutica para modulación inmunológica y preparación de vacunas
SG170127A1 (en) Vaccine compositions comprising a saponin adjuvant
ES2186809T3 (es) Composiciones de vacunas para administracion intranasal, comprendiendo chitosana y su uso.
AR027680A1 (es) Vacuna contra la salmonella materiales y metodos
PE20020968A1 (es) Preparados de insulina exentos de zinc y pobres en zinc, con estabilidad mejorada
NO991524L (no) Vaksiner
DE60144240D1 (de) Zusammensetzung mit immunogenen mikroteilchen
ES2195169T3 (es) Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion.
CY1112658T1 (el) Εμβολια τα οποια περιεχουν αντιγονο μαgε συνδεομενο με θραυσμα πρωτεϊνης d
DK1259259T3 (da) Mucosal adjuvansformulering
BR9704879A (pt) Composição de vacina e uso de um vírus cav vivo
AR020022A1 (es) COMPOSICIONES DE ANTíGENOS DE ERYSILOPELOTHRIX RHUSIOPATHIAE, SU USO EN LA PREPARACIoN DE MEDICAMENTOS Y COMPOSICIONES DE VACUNAS.
ES2166763T3 (es) Inmunizacion parenteral contra rotavirus.
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
ES2102836T3 (es) El empleo de vacunas antihelminticas en el control de la enfermedad parasitaria asociada con la perdida de la inmunidad natural.
BR0013574A (pt) Antìgeno vacina de moraxella
ATE540693T1 (de) Impfung und impfstoffe gegen hundeherpesvirus
ECSP961731A (es) Vacunas

Legal Events

Date Code Title Description
FG Grant, registration